Literature DB >> 7913159

p53 and behaviour of colorectal cancer.

H S Goh1, C S Chan, K Khine, D R Smith.   

Abstract

The tumour suppressor gene p53 is altered in most colorectal tumours. We found that lymphatic dissemination was driven by the presence of mutated p53 whether or not the cell contained wild-type p53. In a total sample of 187 specimens, point mutation of the p53 gene occurred in 70% and 43% of cases with and without lymph-node involvement, respectively. By contrast, haematogenous dissemination was apparently the result of absent functional wild-type p53 (whether or not the cell contained mutated p53). These results are of potential importance in the prediction of the clinical behaviour of a tumour.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7913159     DOI: 10.1016/s0140-6736(94)93000-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  WAF1 expression and p53 mutations in human colorectal cancers.

Authors:  A Wang; N Yoshimi; N Ino; T Tanaka; H Mori
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 2.  What we could do now: molecular pathology of colorectal cancer.

Authors:  R S Houlston
Journal:  Mol Pathol       Date:  2001-08

Review 3.  Colorectal cancer: update on recent advances and their impact on screening protocols.

Authors:  E N Briskey; R J Pamies
Journal:  J Natl Med Assoc       Date:  2000-05       Impact factor: 1.798

4.  ECA39 is a novel distant metastasis-related biomarker in colorectal cancer.

Authors:  Reigetsu Yoshikawa; Hidenori Yanagi; Chun-Shen Shen; Yoshinori Fujiwara; Masafumi Noda; Toshihiko Yagyu; Makoto Gega; Tsutomu Oshima; Takehira Yamamura; Haruki Okamura; Yoshiro Nakano; Tomonori Morinaga; Tomoko Hashimoto-Tamaoki
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

Review 5.  Genetic prognostic markers in colorectal cancer.

Authors:  R S Houlston; I P Tomlinson
Journal:  Mol Pathol       Date:  1997-12

6.  Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer-rarity of co-occurrence of mutations in APC, K-ras, and p53 genes.

Authors:  Jy-Ming Chiang; Yah-Huei Wu Chou; Shih-Chieh Ma; Jim-Ray Chen
Journal:  Virchows Arch       Date:  2004-09-24       Impact factor: 4.064

7.  Prognostic significance of tumor markers in colorectal cancer patients: DNA index, S-phase fraction, p53 expression, and Ki-67 index.

Authors:  Y T Chen; M J Henk; K J Carney; W D Wong; D A Rothenberger; T Zheng; M Feygin; R D Madoff
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

8.  Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum.

Authors:  P A Jackson; M A Green; A Pouli; R Hubbard; C G Marks; M G Cook
Journal:  J Clin Pathol       Date:  1995-12       Impact factor: 3.411

9.  Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.

Authors:  Venkat R Katkoori; Xu Jia; Chandrakumar Shanmugam; Wen Wan; Sreelatha Meleth; Harvey Bumpers; William E Grizzle; Upender Manne
Journal:  Clin Cancer Res       Date:  2009-04-01       Impact factor: 12.531

10.  Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer.

Authors:  Arantza Fariña Sarasqueta; Giusi Forte; Wim E Corver; Noel F de Miranda; Dina Ruano; Ronald van Eijk; Jan Oosting; Rob A E M Tollenaar; Tom van Wezel; Hans Morreau
Journal:  BMC Cancer       Date:  2013-06-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.